1. Show article details.

    Stryker to participate in the Bank of America Securities 2022 Health Care Conference

    GlobeNewswire – 4:05 PM ET 05/02/2022

    Stryker will participate in the Bank of America Securities 2022 Health Care Conference on Wednesday, May 11, 2022. Andy Pierce, Group President, MedSurg and Neurotechnology and Preston Wells, Vice President, Investor Relations will represent the Company in a presentation scheduled for 11:00 a.m. Eastern Time.

  2. Show article details.

    RBC Capital Remains On Sidelines For This MedTech Stock

    Benzinga – 3:11 PM ET 04/29/2022

    RBC Capital Remains On Sidelines For This MedTech Stock

  3. Show article details.

    Stryker reports first quarter 2022 operating results

    GlobeNewswire – 4:05 PM ET 04/28/2022

    Stryker reported operating results for the first quarter of 2022: First Quarter Results "We delivered solid first quarter results in the face of a challenging macroeconomic environment," said Kevin A. Lobo, Chair and CEO. Sales Analysis Consolidated net sales of $4.3 billion increased 8.1% in the quarter and 9.9% in constant currency.

  4. Show article details.

    Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022

    Benzinga – 10:01 AM ET 04/13/2022

    According to Oppenheimer, the prior rating for Apollo Global Management Inc was changed from Perform to Outperform. For Humana Inc, UBS upgraded the previous rating of Neutral to Buy. For NVIDIA Corp, New Street Research upgraded the previous rating of Neutral to Buy. According to Goldman Sachs, the prior rating for Booz Allen Hamilton Holding Corp was changed from Neutral to Buy.

  5. Show article details.

    Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Stryker Corporation (NYSE: SYK) Investors

    GlobeNewswire – 8:44 PM ET 04/07/2022

    The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of investors of Stryker Corporation (SYK). Stryker is a medical technology company that operates through two segments: MedSurg and Neurotechnology and Orthopedics and Spine.

  6. Show article details.

    SYK Alert: Monsey Firm of Wohl & Fruchter LLP Investigating Stryker Corporation for Potential Securities Law Violations

    GlobeNewswire – 10:01 AM ET 04/06/2022

    The law firm of Wohl & Fruchter LLP is investigating whether Stryker Corporation (SYK) has violated federal securities laws. https://wohlfruchter.com/cases/stryker-corporation/ Alternatively, you may contact us by phone at 866-833-6245, or via email at alerts@wohlfruchter.com. Why is there an investigation?

  7. Show article details.

    Stryker to host conference call on April 28, 2022

    GlobeNewswire – 9:00 AM ET 03/30/2022

    Stryker announced that it will host a conference call on Thursday, April 28, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2022 and provide an operational update.Final operating results for the quarter ended March 31, 2022 will be released at 4:05 p.m. that day.

  8. Show article details.

    Stryker announces Annual Meeting of Shareholders

    GlobeNewswire – 3:10 PM ET 03/24/2022

    Stryker announced its 2022 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 4, 2022 – 9:30 a.m. Eastern Time. The Meeting will be held virtually via the internet.

  9. Show article details.

    Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022

    Benzinga – 11:07 AM ET 03/16/2022

    Bernstein upgraded the previous rating for Stryker Corp from Market Perform to Outperform. For Edwards Lifesciences Corp, Bernstein upgraded the previous rating of Market Perform to Outperform. According to Morgan Stanley, the prior rating for KE Holdings Inc was changed from Equal-Weight to Overweight. Northcoast Research upgraded the previous rating for Wingstop Inc from Neutral to Buy.

  10. Show article details.

    Stryker completes acquisition of Vocera Communications

    GlobeNewswire – 8:30 AM ET 02/23/2022

    Stryker announced today that it has completed the previously announced acquisition of Vocera Communications, Inc., a leader in digital care coordination and communication. “This acquisition provides significant opportunities to advance innovations and accelerate our digital aspirations,” said Kevin Lobo, Chair and Chief Executive Officer, Stryker.

  11. Show article details.

    Stryker to participate in Cowen 42nd Annual Health Care Conference

    GlobeNewswire – 11:30 AM ET 02/15/2022

    Stryker will participate in the Cowen 42nd Annual Health Care Conference on Monday, March 7, 2022. Glenn Boehnlein, Vice President, Chief Financial Officer, will represent the Company in a virtual presentation scheduled for 10:30 a.m. Eastern Time.


Today's and Upcoming Events

  • Oct

    SYK to announce Q3 earnings (Unconfirmed)

  • Sep

    SYK ex-Dividend for $0.70 on 09/29/2022

    • Announce Date: 08/03/2022
    • Record Date: 09/30/2022
    • Pay Date: 10/31/2022

Past Events (last 90 days)

  • Jul

    SYK announced Q2 earnings.

  • Jun

    SYK ex-Dividend for $0.70 on 06/29/2022

    • Announce Date: 05/04/2022
    • Record Date: 06/30/2022
    • Pay Date: 07/29/2022
Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.

Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

See the Latest Features
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.